Stay updated on Efgartigimod SubQ in Idiopathic Inflammatory Myopathy Clinical Trial

Sign up to get notified when there's something new on the Efgartigimod SubQ in Idiopathic Inflammatory Myopathy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efgartigimod SubQ in Idiopathic Inflammatory Myopathy Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2. The 'Back to Top' link was removed.
    Difference
    0.2%
    Check dated 2025-09-14T00:11:32.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page has been updated to reflect an increase in study locations from 55 to 58, and the last update date has been revised to August 2025.
    Difference
    2%
    Check dated 2025-09-06T21:04:38.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new facility names and locations, while also removing several previous location entries and medical conditions. Notably, the revision number has been updated from v2.16.12 to v3.0.0.
    Difference
    12%
    Check dated 2025-08-30T15:31:18.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    There are no significant changes to the web page content.
    Difference
    0.4%
    Check dated 2025-08-23T14:10:14.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    1%
    Check dated 2025-08-16T11:46:02.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.6%
    Check dated 2025-08-09T07:09:11.000Z thumbnail image

Stay in the know with updates to Efgartigimod SubQ in Idiopathic Inflammatory Myopathy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efgartigimod SubQ in Idiopathic Inflammatory Myopathy Clinical Trial page.